nafamostat has been researched along with e 64 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Andrade-Gordon, P; Barocelli, E; Cenac, N; Gobbetti, T; Martin, L; Motta, JP; Rolland, C; Steinhoff, M; Vergnolle, N | 1 |
1 review(s) available for nafamostat and e 64
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
2 other study(ies) available for nafamostat and e 64
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.
Topics: alpha-Macroglobulins; Animals; Benzamidines; Chemokines; Cysteine Proteinase Inhibitors; Granulocytes; Guanidines; Intestine, Small; Ischemia; Leucine; Male; Mice; Mice, Inbred C57BL; Peroxidase; Protease Inhibitors; Receptor, PAR-1; Receptor, PAR-2; Reperfusion Injury; Serine Proteinase Inhibitors; Trypsin | 2012 |